TREM1 and Alzheimer disease: found increased amyloid deposition in the mouse brain after TREM-1 inhibition by intracerebral injection of lentiviral particles, whereas TREM-1 overexpression by a lentiviral strategy or agonistic antibodies alleviated AD neuropathology and improved AD-related spatial cognitive deficits.